Celldex Therapeutics Inc
F:TCE2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
Y
|
Ypsomed Holding AG
XMUN:OWX
|
CH |
|
AVROBIO Inc
NASDAQ:TECX
|
US |
|
E
|
Ellington Financial Inc
F:1EL
|
US |
|
B
|
Barrick Gold Corp
DUS:ABR
|
CA |
|
Chemometec A/S
F:CHY
|
DK |
|
V
|
Valneva SE
XMUN:AYJ
|
FR |
|
Royal Bafokeng Platinum Ltd
F:7BF
|
ZA |
|
J
|
Jiangsu Expressway Co Ltd
SWB:JE2
|
CN |
|
Washington H Soul Pattinson and Company Ltd
F:WD3
|
AU |
|
A
|
American International Group Inc
BMV:AIG
|
US |
|
I
|
Industrial and Commercial Bank of China Ltd
XMUN:ICK
|
CN |
|
Wolters Kluwer NV
F:WOS
|
NL |
|
S
|
Scor SE
F:SDRC
|
FR |
|
M
|
Macy's Inc
DUS:FDO
|
US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
US |
|
N
|
Nuvo Pharmaceuticals Inc
F:23N
|
CA |
|
L
|
London Stock Exchange Group PLC
DUS:LS4C
|
UK |
|
N
|
Nordic American Tanker Ltd
LSE:0UC0
|
BM |
|
T
|
Thales SA
XBER:CSF
|
FR |
|
Industrial and Commercial Bank of China Ltd
F:ICKB
|
CN |
|
E
|
Endeavour Silver Corp
XMUN:EJD
|
CA |
|
Fortinet Inc
NASDAQ:FTNT
|
US |
|
Mirait One Corp
F:5FO
|
JP |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
3.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
